Taiwan FDA registration f95436a351e7e4a3e17e4b6760f7d915

"Abbot" Enterovirus 71 immunoglobulin M antibody rapid test

TW: "亞培"百而靈腸病毒71型免疫球蛋白M抗體快速檢驗
Taiwan flagTaiwan·Risk Class 2·ABBOTT DIAGNOSTICS KOREA INC.·Registered Mar 04, 2013 – Mar 04, 2028Active
Registration details
Analysis ID
f95436a351e7e4a3e17e4b6760f7d915
Customs Code
DHA00602454801
Company information
Manufacturer Country
Korea, Republic of
Authorized Representative
Abbott Rapid Diagnostics Health Corp.
Product details
Intended Use
Enterovirus type 71 IgM antibody was qualitatively detected in human serum or plasma samples by solid-phase immunochromography. This test only provides preliminary test results, and more specific diagnostic tools, such as virus isolation, PCR and RT-PCR, are needed to confirm enterovirus type 71 infection.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.0001 腸病毒71型血清試劑
Import Information
import
Dates and status
Registration Date
Mar 04, 2013
Expiry Date
Mar 04, 2028
About this record

Access comprehensive regulatory information for "Abbot" Enterovirus 71 immunoglobulin M antibody rapid test in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f95436a351e7e4a3e17e4b6760f7d915 and manufactured by ABBOTT DIAGNOSTICS KOREA INC.. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices